MIRANDA NGUYEN: Open Payments
NPI 1003421975 · SAN RAFAEL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253 in 12 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $317 · 2025 $253
Food & beverage: $253
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $71 |
| PFIZER INC. | 4 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Lilly USA, LLC | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: NURTEC ODT, CAPLYTA, Ozempic, MOUNJARO, SHINGRIX, JARDIANCE.
Industry payments across CA — which companies pay providers there.
